Sustained-Release Photothermal Microneedles for Postoperative Incisional Analgesia and Wound Healing via Hydrogen Therapy.
Aining Zhang, Xue Jiang, Bingrui Xiong, Jiayi Chen, Xin Liu, Siyuan Wang, Bofu Li, Mian Peng, Wei Li · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In vitro results showed that PDA@ZIF-8@AB nanoparticles can release H₂ continuously for up to 5 days in an acidic microenvironment, while the photothermal properties of PDA facilitated controlled release of QX-314 through 6 cycles of near-infrared (NIR) exposure. The authors concluded that the ZIF‐8‐based hydrogen release system provided localized, long‐lasting anti‐inflammatory effects, while controlled QX‐314 release allowed for customized pain relief, addressing the limitations of conventional pain management strategies. These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in To evaluate the biocompatibility of the nanoparticles, NIH‐3T3 cells were utilized. In vitro results showed that PDA@ZIF-8@AB nanoparticles can release H₂ continuously for up to 5 days in an acidic microenvironment, while the photothermal properties of PDA facilitated controlled release of QX-314 through 6 cycles of near-infrared (NIR) exposure.
What the Researchers Studied
The researchers studied To evaluate the biocompatibility of the nanoparticles, NIH‐3T3 cells were utilized. The study used a in vitro cell-culture laboratory experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 5 min. In vitro results showed that PDA@ZIF-8@AB nanoparticles can release H₂ continuously for up to 5 days in an acidic microenvironment, while the photothermal properties of PDA facilitated controlled release of QX-314 through 6 cycles of near-infrared (NIR) exposure. The authors concluded that the ZIF‐8‐based hydrogen release system provided localized, long‐lasting anti‐inflammatory effects, while controlled QX‐314 release allowed for customized pain relief, addressing the limitations of conventional pain management strategies.
Why These Findings Matter
These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
How Strong Is This Evidence?
This is laboratory evidence from a in vitro cell-culture laboratory experiment. It is most informative for the biological mechanisms, cellular responses, or biochemical outcomes directly measured.
Technical Study Details
H2HUBB classifies this publication as laboratory study with laboratory or cellular evidence. The research population or model was To evaluate the biocompatibility of the nanoparticles, NIH‐3T3 cells were utilized. The study used a in vitro cell-culture laboratory experiment. The reported treatment duration was 5 min.
Limitations and Safety
Reported limitations: The analgesic and wound healing effects of hydrogen (H₂) have gradually been recognized; however, the lack of efficient hydrogen delivery systems remains a major limitation. The ZIF‐8‐based hydrogen release system provided localized, long‐lasting anti‐inflammatory effects, while controlled QX‐314 release allowed for customized pain relief, addressing the limitations of conventional pain management strategies.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.